US Edition
Lilly to hike UK price of Mounjaro weight-loss drug by 170%
Eli Lilly will raise private UK prices for Mounjaro by 45% to over 170% to align with European rates while maintaining NHS access under separate agreements.
- Eli Lilly, a pharmaceutical company, will raise the price of its weight-loss drug Mounjaro in the UK by 170%, with the highest dose increasing from £122 to £330 per month's supply.
- The price increase will not affect patients receiving the drug through the National Health Service , which has negotiated a discounted rate.
- Lilly stated that the previous UK price for Mounjaro was significantly lower than in other European countries, and the increase aims to achieve pricing parity across markets.
Insights by Ground AI
Does this summary seem wrong?
12 Articles
12 Articles
Lilly to hike UK price of Mounjaro weight-loss drug by 170%
Eli Lilly will raise the UK list price of its weight-loss treatment Mounjaro by up to 170%, it said on Thursday, amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the United States.
·United Kingdom
Read Full Article
Cost of weight-loss drug Mounjaro could rise significantly
People paying privately for weight-loss drug Mounjaro in the UK face a rise in the cost of the treatment after manufacturer Eli Lilly said it was increasing the list price of the drug by as much as 170%.It means the suggested price for a month’s supply of the highest dose of the drug will rise from £122 to £330, although the rise for lower doses will be smaller. More generally, retailers who sell the drug may be able to negotiate discounts to th…
Coverage Details
Total News Sources12
Leaning Left3Leaning Right0Center7Last UpdatedBias Distribution70% Center
Bias Distribution
- 70% of the sources are Center
70% Center
L 30%
C 70%
Factuality
To view factuality data please Upgrade to Premium
